Hey

Hey! How can I help you today?

Dmd explain

Reading File
Searching the Web

Duchenne muscular dystrophy pathophysiology clinical features 2025

Finding Sources
Searching PubMed

"Duchenne muscular dystrophy"[MeSH Terms] AND treatment

Reading File
Reading File
Here is a thorough explanation of Duchenne Muscular Dystrophy (DMD):

Duchenne Muscular Dystrophy (DMD)

What Is It?

DMD is the most common severe neuromuscular disease in humans - an X-linked recessive disorder caused by mutations in the dystrophin gene (located at Xp21.2). It has an incidence of approximately 1 in 5,000 male births. About one-third of cases arise from de novo mutations with no family history.

Genetics & Pathophysiology

  • The dystrophin gene is one of the largest in the human genome (~2.4 megabases, 79 exons)
  • Over 7,000 variants are associated with DMD; exon deletions (80%) and duplications are most common
  • A frameshift mutation causes complete absence of the dystrophin protein
  • Dystrophin normally forms a mechanical link between the sarcomere and sarcolemma (muscle cell membrane)
  • Without it, a calcium leak occurs across the membrane, triggering muscle fiber necrosis
  • Repeated cycles of degeneration and regeneration lead to replacement of muscle by fat and fibrous connective tissue

Clinical Features

Early childhood (ages 2-5):
  • Delayed motor milestones
  • Difficulty running, frequent falls
  • Calf pseudohypertrophy (calves look enlarged due to fat infiltration)
  • Gowers' sign - child uses hands to "walk up" legs to stand from the floor
Progression:
  • Progressive proximal muscle weakness (lower limbs first)
  • Most patients lose the ability to walk by ages 10-15
  • Scoliosis and joint contractures develop as weakness progresses
  • By age 20: kyphoscoliosis worsens respiratory compromise
Cardiac involvement:
  • Dilated cardiomyopathy (DCM) due to cardiac fibrosis (most common)
  • Rhythm and conduction abnormalities
  • Can lead to heart failure and fatal arrhythmias
Respiratory:
  • Chronic respiratory insufficiency develops in all patients
  • Cardiorespiratory failure is the primary cause of death
Cognitive/neurological:
  • Lower IQ and nonprogressive cognitive impairment in some patients
  • Associated with autism, ADHD, and learning disorders (correlated with mutation location in the gene)

Diagnosis

TestFinding
Serum CK20-100x elevated (markedly raised due to leaking muscle)
Genetic testingPositive in 90-95% of patients - confirms frameshift mutation
Muscle biopsyUsed if genetic testing is negative; shows fiber necrosis, inflammation, fibrosis, variation in fiber size
ImmunohistochemistryAbsent dystrophin staining (except "revertant fibers")

Treatment

Multidisciplinary approach is essential.
Pharmacological:
  • Glucocorticoids (prednisone 0.75 mg/kg/day or deflazacort 0.9 mg/kg/day) - prolong ambulation, improve muscle strength; deflazacort causes less weight gain
  • ACE inhibitors + beta-blockers - slow cardiac fibrosis progression and manage DCM
Exon-skipping therapies (FDA conditionally approved):
  • Eteplirsen - skips exon 51 (30 mg/kg IV weekly)
  • Golodirsen - skips exon 53 (30 mg/kg IV weekly)
  • Viltolarsen - skips exon 53 (80 mg/kg IV weekly)
  • Casimersen - skips exon 45 (30 mg/kg IV weekly)
These work by restoring a partial reading frame so a truncated but partially functional dystrophin is produced.
Supportive:
  • Physical therapy to prevent contractures
  • Noninvasive ventilation for respiratory failure
  • Spinal fusion for scoliosis when indicated
  • Wheelchairs and assistive devices

Carrier Females

  • Most are asymptomatic (one normal X chromosome compensates)
  • Up to 20% of carrier females can show some symptoms (muscle weakness, elevated CK, or DCM) depending on X-inactivation patterns

DMD vs. Becker MD (BMD)

FeatureDMDBMD
MutationFrameshift - no dystrophinIn-frame - reduced/abnormal dystrophin
Onset2-5 yearsTeens/adulthood
Ambulation loss~12-15 yearsAfter 16 years (often later)
SeveritySevereMilder
Sources: Goldman-Cecil Medicine International Edition; Tietz Textbook of Laboratory Medicine, 7th Edition
This is a shared conversation. Sign in to Orris to start your own chat.